Recruiting
Phase 2

Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

Sponsor:

National Cancer Institute (NCI)

Code:

NCT05554367

Conditions

Exocrine Pancreas Carcinoma

Malignant Solid Neoplasm

Ovarian Low Grade Serous Adenocarcinoma

Stage IV Ovarian Cancer AJCC v8

Stage IV Pancreatic Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Binimetinib

Biopsy

Biospecimen Collection

Bone Scan

Computed Tomography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information